Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

GKB OPHTHALMICS LTD.

NSE : NABSE : 533212ISIN CODE : INE265D01015Industry : Medical Equipment/Supplies/AccessoriesHouse : GKB

BSE106.003.35 (+3.26 %)

PREV CLOSE ( ) 102.65

OPEN PRICE ( ) 97.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 8810

TODAY'S LOW / HIGH ( )97.00 106.85

52 WK LOW / HIGH ( ) 74.1136.4

NSE

This Company is not listed in NSE

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 10-12 1981

Management Info

KG Gupta - Chairman KG Gupta - Managing Director

Registered Office

Address 16- A,Tivim Industrial Estate, ,
Mapusa,
Goa-403526

Phone 0832 2257253 / 6714444

Email gkbophthalmics@gkb.net

Website www.gkb.net

Registrars Details

Link Intime India Pvt Ltd.

C 101, 247 Park,L B S Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE, Chennai, Kolkata

NEWS

30Mar GKB Ophthalmics informs about disclosu
Pursuant to provision of Regulation 7(2) read with Regulation 6(2) of SE..

17Jan Gkb Ophthalmics informs about certific
Gkb Ophthalmics has informed that it enclosed Certificate under Regulati..

11Oct Gkb Ophthalmics informs about AGM minu
Gkb Ophthalmics has informed that it enclosed a copy of the Minutes of t..

13Jul GKB Ophthalmics informs about complian
GKB Ophthalmics has informed that it enclosed compliances-certificate un..

19Apr GKB Ophthalmics informs about complian
Pursuant to Regulation 40(10) of SEBI (Listing Obligations and Disclosur..

Financials

Rs. in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	-3.1	-28.8200000000001
Gross Profit	-3.09	-30.3900000000001
Operating Profit	7.09	9.94999999999993
Net Sales	68.43	277.29

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Poly Medicure (BSE) 1605.70 (1.06%)	M.Cap ( in Cr)15410.13
Amkay Products (BSE) 120.96 (5.00%)	M.Cap ( in Cr)104.70
Hemant Surgical Inds (BSE) 141.40 (3.51%)	M.Cap ( in Cr)147.62
Raaj Medisafe India (BSE) 64.10 (5.00%)	M.Cap ( in Cr)84.69
Prevest Denpro (BSE) 379.60 (0.74%)	M.Cap ( in Cr)455.63

Shareholding Pattern

	PROMOTERS	50.93%
	NON-INSTITUTION	47.28%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

GKB OPHTHALMICS LTD.